Isoprostanes are a family of compounds produced from polyunsaturated fatty
acids via a free-radical-catalysed mechanism. F-2-isoprostanes are prostagl
andin F-2 alpha isomers derived from arachidonic acid. These compounds indu
ce potent vasoconstriction, mediated primarily by TP receptor stimulation,
and in some vessels by the release of cyclooxygenase products. This vasocon
striction may be modulated by the endothelium through the release of NO. Po
tent vasoconstriction is also observed with E-2-isoprostanes. Experimental
and clinical data suggest a role for F-2-isoprostanes in atherogenesis, The
se compounds can be detected in free forms in biological fluids as well as
esterified in low-density lipoproteins or cell membranes. Their quantificat
ion represents a reliable marker of lipid peroxidation. Elevated levels of
F-2-isoprostanes in biological fluids in pathological conditions including
atherosclerosis, ischaemia-reperfusion injury, and inflammatory vascular di
seases, suggest a relationship between lipid peroxidation and such diseases
. F-2-isoprostanes are currently being investigated as non-invasive quantit
ative markers to monitor the response to anti-oxidant treatment. Copyright
(C) 2001 S. Karger AG, Basel.